Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 30, 2021

SELL
$212.38 - $245.9 $856,953 - $992,206
-4,035 Closed
0 $0
Q4 2020

Feb 05, 2021

SELL
$212.5 - $245.46 $47,387 - $54,737
-223 Reduced 5.24%
4,035 $896,000
Q3 2020

Nov 13, 2020

BUY
$177.16 - $215.33 $46,593 - $56,631
263 Added 6.58%
4,258 $917,000
Q2 2020

Aug 14, 2020

BUY
$128.7 - $176.83 $4,118 - $5,658
32 Added 0.81%
3,995 $707,000
Q1 2020

May 15, 2020

BUY
$121.39 - $169.05 $481,068 - $669,945
3,963 New
3,963 $549,000
Q4 2019

Feb 13, 2020

SELL
$133.47 - $153.48 $207,278 - $238,354
-1,553 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$135.4 - $146.47 $210,276 - $227,467
1,553 New
1,553 $224,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.